90139-67-6

Basic information

• Product Name: 2-Oxa-4,9,14-triazaoctadecan-18-oic acid, 3,8,13-trioxo-1-phenyl-, methyl ester
• CAS NO: 90139-67-6
• Molecular Formula: C21H31N3O6
• Molecular Weight: 421.494
• Mol File: 90139-67-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-Oxa-4,9,14-triazaoctadecan-18-oic acid, 3,8,13-trioxo-1-phenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Oxa-4,9,14-triazaoctadecan-18-oic acid, 3,8,13-trioxo-1-phenyl-, methyl ester(90139-67-6)
• EPA Substance Registry System: 2-Oxa-4,9,14-triazaoctadecan-18-oic acid, 3,8,13-trioxo-1-phenyl-, methyl ester(90139-67-6)

Safety Data

• Hazardous Substances Data: 90139-67-6(Hazardous Substances Data)

Upstream product

• 90139-76-7 4-(4-Benzyloxycarbonylamino-butyrylamino)-butyric acid methyl ester 
• 5105-78-2 4-(benzyloxycarbonylamino)butyric acid 
• 13031-60-2 methyl γ-aminobutyrate hydrochloride 
• 1489-76-5 4-(4-Benzyloxycarbonylamino-butyrylamino)-butyric acid 
• 103321-35-3 4-(4-Amino-butyrylamino)-butyric acid methyl ester; hydrochloride 

Downstream Products

• 103321-45-5 (S)-2-{4-[4-(4-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-butyrylamino)-butyrylamino]-butyrylamino}-pentanedioic acid di-tert-butyl ester 
• 103321-30-8 (S)-2-{4-[4-(4-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-butyrylamino)-butyrylamino]-butyrylamino}-pentanedioic acid 
• 103346-42-5 (S)-2-{4-[4-(4-Benzyloxycarbonylamino-butyrylamino)-butyrylamino]-butyrylamino}-pentanedioic acid di-tert-butyl ester 
• 90139-74-5 4-[4-(4-Benzyloxycarbonylamino-butyrylamino)-butyrylamino]-butyric acid 

Relevant articles and documents

Ligands for expression cloning and isolation of GABAB receptors

The scope of the plenary lecture at the occasion of the Xth Meeting on Heterocyclic Structures in Medicinal Chemistry, Palermo 2002, is considerably larger than that of the main lecture at the XVIth International Symposium on Medicinal Chemistry, Bologna 2000, described by Froestl et al. in Farmaco 56 (2001) 101. Additional information is presented, in particular, on the reaction conditions for the 31 step synthesis of the combined affinity chromatography and photoaffinity radioligand [125I]CGP84963 and on the recent developments of the molecular biology of GABAB receptors.